Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
暂无分享,去创建一个
Li Ding | Jinghui Zhang | Matthew Parker | Heather L. Mulder | Michael Edmonson | Elaine R Mardis | Michael Rusch | Chunxu Qu | Erin K. Hedlund | John Easton | Lei Wei | Yongjin Li | Sheila Shurtleff | Panduka Nagahawatte | Gang Wu | Michael C. Rusch | Michael N. Edmonson | Erin Hedlund | Armita Bahrami | R. Wilson | E. Mardis | J. Downing | S. Shurtleff | L. Ding | M. Edmonson | Chunxu Qu | Charles Lu | D. Ellison | J. Easton | Gang Wu | Xiang Chen | A. Bahrami | A. Pappo | M. Rusch | Panduka Nagahawatte | Jianmin Wang | M. Parker | Lei Wei | Erin Hedlund | Kristy Boggs | H. Mulder | D. Yergeau | Jinghui Zhang | M. Dyer | N. Daw | Yongjin Li | J. Dalton | Richard K Wilson | Xiang Chen | Kristy Boggs | Donald Yergeau | Charles Lu | James R Downing | Alberto Pappo | Heather Mulder | Michael A Dyer | F. Navid | Jianrong Wu | Jianrong Wu | David Ellison | S. Mao | Fariba Navid | James Dalton | Najat C Daw | Jianmin Wang | Shenghua Mao | Matthew Parker | R. Wilson
[1] D. Slamon,et al. Frequency and structure of p53 rearrangements in human osteosarcoma. , 1990, Cancer research.
[2] S. Friend,et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Ladanyi,et al. p53 and MDM2 alterations in osteosarcomas , 1997, Cancer.
[4] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[5] W. J. Kent,et al. BLAT--the BLAST-like alignment tool. , 2002, Genome research.
[6] R. Cawthon. Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.
[7] L. Chin,et al. High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Kleinerman,et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. Tucker,et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] S. Bull,et al. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Hicks,et al. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] G. Ottaviani,et al. The epidemiology of osteosarcoma. , 2009, Cancer treatment and research.
[13] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[14] S. Altekruse,et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Andrew Menzies,et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.
[16] Kiran C. Bobba,et al. Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project , 2011 .
[17] Kenneth H. Buetow,et al. Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .
[18] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[19] Eric S. Lander,et al. The genomic complexity of primary human prostate cancer , 2010, Nature.
[20] Jinghui Zhang,et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. , 2012, JAMA.
[21] Li Ding,et al. The Pediatric Cancer Genome Project , 2012, Nature Genetics.
[22] Elaine R. Mardis,et al. Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.
[23] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[24] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[25] Heather L. Mulder,et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. , 2013, Cancer cell.
[26] A. Sivachenko,et al. Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.
[27] Cheng Cheng,et al. A genomic random interval model for statistical analysis of genomic lesion data , 2013, Bioinform..
[28] J. Korbel,et al. Criteria for Inference of Chromothripsis in Cancer Genomes , 2013, Cell.